MSN Laboratories Private Limited Carmustine Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Carmustine Export Records India — #2 Exporter, 17 Shipments, $850.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Carmustine

India Pharmaceutical Trade Intelligence

$22.5M50 Suppliers54 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM58.1%India → CANADA12.6%

ImportsAUSTRALIA → India$6.1K TAIWAN → India$153

#1 Supplier: EMCURE PHARMACEUTICALS

MSN Laboratories Private Limited — Carmustine Exporter #2 | $850.0K Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Carmustine Exporter Profile

Indian Pharmaceutical Exporter · #2 for Carmustine · $850.0K export value · DGFT Verified

MSN Laboratories Private Limited is the #2 Indian exporter of Carmustine with $850.0K in export value and 17 verified shipments. MSN Laboratories Private Limited holds a 3.8% market share in Carmustine exports across 4 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Carmustine Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Carmustine export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Carmustine?

Country	Value	Shipments	Share
CANADA	$303.3K	9	69.2%
MALTA	$114.3K	6	26.1%
UNITED STATES	$20.4K	1	4.7%
SWEDEN	$97	1	0.0%

Who Are the Top Buyers of Carmustine from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
STERIMAX INC	CANADA	$253.0K	7
PHARMADOX HEALTHCARE LTD	MALTA	$64.0K	2
TO THE ORDER OF	CANADA	$50.0K	1
PHARMADOX HEALTHCARE LIMITED	MALTA	$50.0K	1
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$20.4K	1
PHARMADOX HEALTHCARE LTD.,	MALTA	$241	3
STERIMAX INC.	CANADA	$232	1
SWEDISH MEDICAL PRODUCTS AGENCY LAKEMEDELSVERKET DAG HAMMARSKJOLDSVAG	SWEDEN	$97	1

MSN Laboratories Private Limited supplies Carmustine to 8 buyers globally. The largest buyer is STERIMAX INC (CANADA), followed by PHARMADOX HEALTHCARE LTD (MALTA) and TO THE ORDER OF (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Carmustine Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
CARMUSTINE FOR INJECTION USP 100 MG (900PAC)	$100.0K	2
MSN PHARMA CARMUSTINE FOR INJECTION USP100 MG	$50.0K	1
CARMUSTINE FOR INJECTION USP 100 MG (350PAC)	$50.0K	1
CARMUSTINE FOR INJECTION USP 100 MG (900PAC)900NOS550	$50.0K	1
CARMUSTINE FOR INJECTION USP 100 MG (350PAC)350NOS550	$50.0K	1
CARMUSTINE 100MG VIAL ES (SENDING ALONGWITH 200 NOS AS FREE SAMPLE)	$50.0K	1
CARMUSTINE 100MG VIAL DE (SENDING ALONGWITH 180 NOS AS FREE SAMPLE)	$45.3K	1
CARMUSTINE INJECTION 100 MG/VIAL 1S	$20.4K	1
CARMUSTINE 100MG VIAL ES-809245 (SENDINGALONG WITH 179 NOS AS FREE SAMPLE)	$18.8K	1
CARMUSTINE DILUENT VIAL (61 PAC)	$1.5K	1

MSN Laboratories Private Limited exports 16 distinct Carmustine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CARMUSTINE FOR INJECTION USP 100 MG (900PAC) with 2 shipments worth $100.0K.

How Does MSN Laboratories Private Limited Compare to Nearest Carmustine Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	EMCURE PHARMACEUTICALS LIMITED	$4.0M	81	19	$50.0K
2	MSN LABORATORIES PRIVATE LIMITED ★	$850.0K	17	4	$50.0K
3	INTAS PHARMACEUTICALS LIMITED	$778.2K	44	6	$17.7K
4	THERDOSE PHARMA PRIVATE LIMITED	$455.2K	22	8	$20.7K

MSN Laboratories Private Limited ranks #2 among 50 Indian Carmustine exporters. Average shipment value of $50.0K compared to the market average of $129.7K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Carmustine Exports?

Port	Shipments	% Share
SAHAR AIR	67	19.7%
SAHAR AIR CARGO ACC (INBOM4)	45	13.2%
HYDERABAD AIR	38	11.2%
HYDERABAD ACC (INHYD4)	28	8.2%
AHEMDABAD AIR ACC (INAMD4)	23	6.8%
Bombay Air	18	5.3%
DELHI AIR	15	4.4%
AHEMDABAD AIR	11	3.2%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Carmustine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Carmustine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 17 individual customs records matching MSN Laboratories Private Limited exporting Carmustine, covering 16 formulations to 4 countries via 8 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 54+ countries, 135+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Carmustine

Carmustine

MSN Laboratories Private Limited — Carmustine Exporter Profile

MSN Laboratories Private Limited — Carmustine Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Carmustine?

Who Are the Top Buyers of Carmustine from MSN Laboratories Private Limited?

What Is India's Total Carmustine Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Carmustine Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Carmustine Exporters?

What Carmustine Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Carmustine to Key Markets

Canada — HC

United States — FDA

How Does MSN Laboratories Private Limited Compare to Nearest Carmustine Exporters?

Which Indian Ports Ship Carmustine Exports?

What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Carmustine Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Carmustine Export Data from MSN Laboratories Private Limited

Carmustine Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source